Home | American Pharmacists Association

News View all news

August 20, 2019

EPA rule banning disposal of drugs down drains takes effect this week

The first deadline of a new rule from the Environmental Protection Agency (EPA) governing the handling of hazardous waste pharmaceuticals by health care facilities will take effect Wednesday, August 21, 2019. The EPA rule, Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine, prohibits the disposal of certain drugs by flushing them down the drain or toilet—commonly referred to as “sewering”—and eases rules about disposing of FDA-approved, OTC nicotine replacement therapies, among other changes related to hazardous waste pharmaceuticals of which pharmacists need to be aware.

August 19, 2019

Anticholinergic drug exposure increases risk of dementia, study finds

An observational study published in JAMA Internal Medicine found that middle-aged and older adults who used anticholinergic drugs such as antidepressants, antiparkinson agents, antipsychotics, antimuscarinics, and antiepileptics had an increased risk of dementia.

August 19, 2019

CDC says males and females up to age 26 should receive HPV catch-up vaccine

CDC has formalized the June 2019 Advisory Committee on Immunization Practices’ (ACIP’s) recommendation for both men and women to receive a catch-up human papilloma (HPV) vaccination up to 26 years of age. For average-risk men, the previous cutoff was age 21. Catch-up HPV vaccination has already been recommended for females through age 26 and certain special populations.

August 13, 2019

Inspired by your pharmacy colleagues? Consider nominating them for an APhA award

Our teachers, bosses, and colleagues shape our perspective and influence the way we practice every day. If you’re inspired by a leader who paved a path for you, a mentor who shepherded you, or a teammate who motivated you, consider nominating them for one of APhA’s awards and honors. The APhA Awards and Honors Program recognizes excellence in both new and established pharmacy careers and across practice settings.

August 12, 2019

Treatment with NSAIDs may increase CVD risk in patients with osteoarthritis

NSAIDs, which are often used to treat pain and inflammation in patients with osteoarthritis, may contribute to the increased risk of cardiovascular disease (CVD) in these patients, according to a new study published on August 6, 2019, in Arthritis & Rheumatology.

Students

Let APhA help you through your pharmacy training and beyond.

Learn More

New Practitioners

Your career starts here. Get the tools you need to kick-start your career.

Learn More

Pharmacists

Reach your full potential as a pharmacist with these helpful practice tools and resources.

Learn More

Pharmacy Technicians

Media/Press

Not a member? See What APhA can do for you

CEO Blog

by Thomas E. Menighan

View all CEO blog posts

August 13, 2019

Have you lost your job or had your hours cut? If so, APhA has an…

As you all know, our profession has faced widespread workforce challenges over the last few months. Last month, I told you about APhA’s efforts to respond to many of these problems. While we…

DIR relief making slow moves, but it’s a start

Earlier today, the Senate Finance Committee marked up the package of legislation on drug prices and supply chain issues that was introduced on Tuesday. Among many other aims, the sweeping legislation…

Press Releases

View all press releases

August 6, 2019

APhA Statement on the Recent Shooting Tragedies

The American Pharmacists Association (APhA) is deeply saddened by the horrific mass shootings that occurred over the weekend in Texas and Ohio where at least 31 people were killed. As an organization representing a profession that provides health care and support for communities and citizens around the country, APhA condemns any act of violence. APhA President Bradley P. Tice, PharmD, MBA, FAPhA, issued the following statement on behalf of himself and the APhA Board of Trustees.

July 29, 2019

National Pharmacy Organizations Address Pharmacist Well-Being Through Consensus Conference Recommendations

In response to rapid changes in pharmacy practice models and a changing and evolving health care system that impacting the well-being of the nation’s pharmacists, 85 individuals representing pharmacists and employers from across practice settings, schools and colleges of pharmacy, regulators, accreditors, and professional organizations have agreed to a set of 50 recommendations to address critical issues related to pharmacist well-being.

Why APhA?

APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use. We strive to make your job as a pharmacist easier, by providing the latest industry news, continuing education and professional development opportunities, practice tools, and more, so that you can focus on caring for your patients.